Elevated concentration of IL-6 had been indicated as a stable indicator for the progression and adverse endpoint of COVID-19, and IL-6 and IL-10 were significantly related with the positivity duration of SARS-CoV-2 [31, 32], which were consistent with our findings. This evidence concerns the gene IL10 and COVID-19.